Gibot S - Search Results

1

Nangibotide in patients with septic shock: a Phase 2a randomized controlled clinical trial.

François B, Wittebole X, Ferrer R, Mira JP, Dugernier T, Gibot S, Derive M, Olivier A, Cuvier V, Witte S, Pickkers P, Vandenhende F, Garaud JJ, Sánchez M, Salcedo-Magguilli M, Laterre PF. François B, et al. Among authors: gibot s. Intensive Care Med. 2020 Jul;46(7):1425-1437. doi: 10.1007/s00134-020-06109-z. Epub 2020 May 28. Intensive Care Med. 2020. PMID: 32468087 Clinical Trial.

2

Histocompatibility leukocyte antigen-D related expression is specifically altered and predicts mortality in septic shock but not in other causes of shock.

Caille V, Chiche JD, Nciri N, Berton C, Gibot S, Boval B, Payen D, Mira JP, Mebazaa A. Caille V, et al. Among authors: gibot s. Shock. 2004 Dec;22(6):521-6. doi: 10.1097/01.shk.0000143410.63698.57. Shock. 2004. PMID: 15545822

3

Surface triggering receptor expressed on myeloid cells 1 expression patterns in septic shock.

Gibot S, Le Renard PE, Bollaert PE, Kolopp-Sarda MN, Béné MC, Faure GC, Lévy B. Gibot S, et al. Intensive Care Med. 2005 Apr;31(4):594-7. doi: 10.1007/s00134-005-2572-x. Epub 2005 Mar 8. Intensive Care Med. 2005. PMID: 15754199

4

Surface and soluble triggering receptor expressed on myeloid cells-1: expression patterns in murine sepsis.

Gibot S, Massin F, Le Renard P, Béné MC, Faure GC, Bollaert PE, Levy B. Gibot S, et al. Crit Care Med. 2005 Aug;33(8):1787-93. doi: 10.1097/01.ccm.0000172614.36571.75. Crit Care Med. 2005. PMID: 16096457

5

Cardiovascular response to dopamine and early prediction of outcome in septic shock: a prospective multiple-center study.

Levy B, Dusang B, Annane D, Gibot S, Bollaert PE; College Interregional des Réanimateurs du Nord-Est. Levy B, et al. Among authors: gibot s. Crit Care Med. 2005 Oct;33(10):2172-7. doi: 10.1097/01.ccm.0000181297.14319.3c. Crit Care Med. 2005. PMID: 16215366 Clinical Trial.

6

Myocardial lactate deprivation is associated with decreased cardiovascular performance, decreased myocardial energetics, and early death in endotoxic shock.

Levy B, Mansart A, Montemont C, Gibot S, Mallie JP, Regnault V, Lecompte T, Lacolley P. Levy B, et al. Among authors: gibot s. Intensive Care Med. 2007 Mar;33(3):495-502. doi: 10.1007/s00134-006-0523-9. Epub 2007 Jan 23. Intensive Care Med. 2007. PMID: 17242933

7

High-mobility group box 1 protein plasma concentrations during septic shock.

Gibot S, Massin F, Cravoisy A, Barraud D, Nace L, Levy B, Bollaert PE. Gibot S, et al. Intensive Care Med. 2007 Aug;33(8):1347-53. doi: 10.1007/s00134-007-0691-2. Epub 2007 May 25. Intensive Care Med. 2007. PMID: 17525840

8

Osteopontin in sepsis: any role?

Derive M, Gibot S. Derive M, et al. Among authors: gibot s. Intensive Care Med. 2008 Dec;34(12):2134-5. doi: 10.1007/s00134-008-1275-5. Epub 2008 Sep 20. Intensive Care Med. 2008. PMID: 18807010 No abstract available.

9

Effects of the TREM 1 pathway modulation during hemorrhagic shock in rats.

Gibot S, Massin F, Alauzet C, Derive M, Montemont C, Collin S, Fremont S, Levy B. Gibot S, et al. Shock. 2009 Dec;32(6):633-7. doi: 10.1097/SHK.0b013e3181a53842. Shock. 2009. PMID: 19333144

10

Probiotics in the critically ill patient: a double blind, randomized, placebo-controlled trial.

Barraud D, Blard C, Hein F, Marçon O, Cravoisy A, Nace L, Alla F, Bollaert PE, Gibot S. Barraud D, et al. Among authors: gibot s. Intensive Care Med. 2010 Sep;36(9):1540-7. doi: 10.1007/s00134-010-1927-0. Epub 2010 May 26. Intensive Care Med. 2010. PMID: 20502866 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

167 results

Search Page